The Efficacy and Safety of a Novel Injectable Cr-Insulin Formulation for the Treatment of Type 1 Diabetes

被引：0
|
作者：
Sahin, Kazim
Orhan, Cemal
Tuzcu, Mehmet
Sahin, Nurhan
Gencoglu, Hasan
Ilhan, Necip
Hayirli, Armagan
Ozkan, Yusuf
Komorowski, James R.
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1129-P
引用
收藏
页码：A310 / A310
页数：1
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OF FASTER ASPART COMPARED WITH INSULIN ASPART IN TYPE 1 DIABETES
    Klonoff, D.
    Evans, M.
    Lane, W.
    Kempe, H. P.
    Renard, E.
    DeVries, H.
    Graungaard, T.
    Hyseni, A.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A32 - A33
  • [42] Safety of injectable semaglutide for type 2 diabetes
    Peter, Rajesh
    Bain, Steve C.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (07) : 785 - 798
  • [43] Insulin aspart in pregnancy: Protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes
    Hod, M
    Amiel, S
    Damm, P
    Dunne, F
    Heller, S
    Lertoft, B
    Mathiesen, E
    Mccance, D
    Visser, G
    DIABETES, 2003, 52 : A567 - A567
  • [44] Efficacy and Safety of Continuous Subcutaneous Insulin Infusion Therapy in Pregnancy Complicated by Type 1 Diabetes
    Cyganek, Katarzyna
    Hebda-Szydlo, Alicja
    Katra, Barbara
    Klupa, Tomasz
    Kaim, Irena
    Reron, Alfred
    Malecki, Maciej T.
    DIABETES, 2009, 58 : A466 - A467
  • [45] Efficacy and safety of continuous subcutaneous insulin infusion therapy in pregnancy complicated by type 1 diabetes
    Cyganek, K.
    Hebda-Szydlo, A.
    Katra, B.
    Klupa, T.
    Kaim, I.
    Skupien, J.
    Reron, A.
    Sieradzki, J.
    Malecki, M. T.
    DIABETOLOGIA, 2009, 52 : S462 - S462
  • [46] Safety and efficacy of insulin aspart and soluble human insulin in Type 2 diabetes mellitus
    Cucinotta, D.
    Caputo, S.
    Mannucci, E.
    Nicolucci, A.
    Pellegrini, F.
    Perriello, G.
    Sbraccia, P.
    MINERVA ENDOCRINOLOGICA, 2012, 37 (04) : 357 - 366
  • [47] Intensification of type 1 diabetes Mellitus (DM 1) treatment: Efficacy of detemir as basal insulin
    Della Manna, T.
    Nakao, T.
    Savoldelli, R.
    Menezes-Filho, H.
    Steinmetz, L.
    Kuperman, H.
    Damiani, D.
    HORMONE RESEARCH, 2007, 68 : 8 - 8
  • [48] Intensification of type 1 diabetes mellitus (DM 1) treatment: Efficacy of detemir as basal insulin
    Manna, Thais D.
    Savoldelli, Roberta D.
    Nakao, Tatiana
    Menezes-Filho, Hamilton C.
    Steinmetz, Leandra
    Kuperman, Hilton
    Setian, Nuvarte
    Damiani, Durval
    HORMONE RESEARCH, 2008, 70 : 210 - 210
  • [49] Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes
    Cao, Ying
    Gao, Fang
    Zhang, Qian
    Xu, Lingling
    Wan, Qian
    Li, Wenqi
    Li, Jimin
    Wang, Ling
    Xue, Yaoming
    JOURNAL OF DIABETES, 2017, 9 (05) : 502 - 509
  • [50] Efficacy and safety of insulin treatment in type 2 diabetes using a new index called glucose safety control index
    CAI Xiao-ling
    LUO Ying-ying
    HAN Xue-yao
    JI Li-nong
    中华医学杂志（英文版）, 2013, 126 (21) : 4166 - 4174
12345